Skip to content

Difference of bone mineral density between postmenopausal women with and without metabolic syndrome

Difference of bone mineral density between postmenopausal women with and without metabolic syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20160411002
Enrollment
Unknown
Registered
2016-04-11
Start date
2015-05-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postmenopausal women metabolic syndrome postmenopausal metabolic syndrome

Interventions

women age between 45 and 65 years&#44
>1 year since her last period and diagnosed metabolic syndrome&#44
according to NCEP ATP III (3/5) 1. Abdominal obesity (≥ 80 cm) 2. Hypertriglyceridemia ( ≥ 150 mg/dL ) 3. Low HDL cholesterol (130/85 mmHg or use of antihypertensive agent) 5. High fasting glucos
postmenopausal women who comparable with metabolic syndrome group
Health Services Research,Health Services Research
postmenopausal women with metabolic syndrome,postmenopausal women without metabolic syndrome

Sponsors

Khon Kaen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Postmenopausal women who agreed to include in the study Age between 45 and 65 years More than 1 year since her last period Menopause at ≥ 45 years old by natural or surgical menopause Diagnosed metabolic syndrome, according to the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) : ≥ 3 / 5 (Abdominal obesity [≥ 80 cm for women; criteria for Asian population], Hypertriglyceridemia [≥ 150 mg/dL], Low HDL cholesterol [ 130/ 85 mmHg or use of antihypertensive agent], High fasting glucose [≥ 100 mg/dL] or use of hypoglycemic agents

Exclusion criteria

Exclusion criteria: Taking hormone replacement therapy > 6 months Taking medication for osteoporosis Taking steroid more than 3 months Rheumatoid arthritis Thyroid disease or thyroid functional abnormality Malignancy, ESRD, immune deficiency, cardiovascular failure Cerebrovascular disease/ dementia Psychiatric disease Difficult to communicate due to disability

Design outcomes

Primary

MeasureTime frame
bone mineral density of postmenopausal women who had MS and non-MS at the time of recruitment DXA scan

Secondary

MeasureTime frame
the association of each components of MS and BMD at analysis Multiple linear regression

Countries

Thailand

Contacts

Public ContactSiriruthai Amnatbuddee

Faculty of Medicine, Khon Kaen University

s_auang@hotmail.com0817396331

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026